ApoPharma - DRIVING INNOVATION
ApoPharma - TREAT
ApoPharma - DISCOVER
ApoPharma - INFORM
Learn more about our products for the treatment of transfusional iron overload in thalassemia when current chelation therapy is inadequate.
Learn more about our product for the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary.
Learn more about our product for palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
Learn more about our product for the treatment of acute iron toxicity and chronic iron overload due to transfusion-dependent anemias.
ApoPharma's global partnerships and collaborations have enhanced our expertise in scientific discovery and drug development to bring new medicines to market.
*All other brand or product names located in this site are trademarks of their respective holders. © ApoPharma Inc. 2018. All rights reserved.